Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study : JAIDS Journal of Acquired Immune Deficiency Syndromes

Secondary Logo

Journal Logo

Prevention Research

Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study

Morris, Sheldon R. MD, MPHa; Jain, Sonia PhDa; Blumenthal, Jill MDa; Bolan, Robert MDb; Dubé, Michael P. MDc; Henderson, Philip MDd; Corado, Katya MDe; Sun, Shelly MSa; He, Feng MSa; Chow, Karen BSca; Burke, Leah MPHa; Anderson, Peter L. PharmDf; Moore, David J. PhDa

Author Information
JAIDS Journal of Acquired Immune Deficiency Syndromes 91(5):p 453-459, December 15, 2022. | DOI: 10.1097/QAI.0000000000003091

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid